Dimiracetam
Dimiracetam is a nootropic drug of the racetam family,[1] derivatives of which may have application in the treatment of neuropathic pain.[2]
Names | |
---|---|
IUPAC name
(RS)-3,6,7,7a-Tetrahydro-1H-pyrrolo[1,2-a]imidazole-2,5-dione | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChEMBL | |
ChemSpider | |
PubChem CID |
|
UNII | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula |
C6H8N2O2 |
Molar mass | 140.142 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
References
- Pinza, M; Farina, C; Cerri, A; Pfeiffer, U; Riccaboni, MT; Banfi, S; Biagetti, R; Pozzi, O; et al. (1993). "Synthesis and pharmacological activity of a series of dihydro-1H-pyrrolo1,2-aimidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers". Journal of Medicinal Chemistry. 36 (26): 4214–20. doi:10.1021/jm00078a011. PMID 8277504.
- Farina, C; Gagliardi, S; Ghelardini, C; Martinelli, M; Norcini, M; Parini, C; Petrillo, P; Ronzoni, S (2008). "Synthesis and biological evaluation of novel dimiracetam derivatives useful for the treatment of neuropathic pain". Bioorganic & Medicinal Chemistry. 16 (6): 3224–32. doi:10.1016/j.bmc.2007.12.015. PMID 18171618.
This article is issued from
Wikipedia.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.